Form 13-F position report

HCA HEALTHCARE INC COM STK

Reported by VANGUARD GROUP INC

HCA CUSIP 40412C101 Manager CIK 0000102909

Reported 14,894,675 shares, down 580,889 (3.8%) from the prior quarter.

Reported value 7.1%; share count -3.8% vs. the prior quarter.

Reduced
% of reported 13F value 0.1% This manager · Q3 2025
Shares 14,894,675 Quarter-end amount reported
Reported value $6,348,110,485 Fair value at quarter end
Consecutive quarters held 50 Through Q3 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-03-31 3957941000
2021-06-30 4338360000
2021-09-30 4851167000
2021-12-31 4863919000
2022-03-31 4790225000
2022-06-30 3128816000
2022-09-30 3324472000
2022-12-31 4306494452
2023-03-31 4716890833
2023-06-30 5305515658
2023-09-30 4213543189
2023-12-31 4582444307
2024-03-31 5666568971
2024-06-30 5410199380
2024-09-30 6510172981
2024-12-31 4750902064
2025-03-31 5442954667
2025-06-30 5928688570
2025-09-30 6348110485
2025-12-31 6870392526

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for HCA HEALTHCARE INC COM STK held by VANGUARD GROUP INC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2025 Reduced 14,716,173 -178,502 (-1.2%) 0.1% $6,870,392,526 2026-01-29
Q3 2025 Reduced 14,894,675 -580,889 (-3.8%) 0.1% $6,348,110,485 2025-11-07
Q2 2025 Reduced 15,475,564 -276,005 (-1.8%) 0.1% $5,928,688,570 2025-08-11
Q1 2025 Reduced 15,751,569 -76,857 (-0.5%) 0.1% $5,442,954,667 2025-05-09
Q4 2024 Reduced 15,828,426 -189,518 (-1.2%) 0.08% $4,750,902,064 2025-02-11
Q3 2024 Reduced 16,017,944 -821,571 (-4.9%) 0.12% $6,510,172,981 2024-11-13
Q2 2024 Reduced 16,839,515 -150,168 (-0.9%) 0.1% $5,410,199,380 2024-08-13
Q1 2024 Added 16,989,683 +60,304 (0.4%) 0.11% $5,666,568,971 2024-05-10
Q4 2023 Reduced 16,929,379 -200,238 (-1.2%) 0.1% $4,582,444,307 2024-02-14
Q3 2023 Reduced 17,129,617 -352,641 (-2.0%) 0.1% $4,213,543,189 2023-11-14
Q2 2023 Reduced 17,482,258 -406,436 (-2.3%) 0.13% $5,305,515,658 2023-08-14
Q1 2023 Reduced 17,888,694 -58,024 (-0.3%) 0.12% $4,716,890,833 2023-05-15
Q4 2022 Reduced 17,946,718 -141,715 (-0.8%) 0.12% $4,306,494,452 2023-02-10
Q3 2022 Reduced 18,088,433 -528,820 (-2.8%) 0.1% $3,324,472,000 2022-11-14
Q2 2022 Reduced 18,617,253 -496,245 (-2.6%) 0.09% $3,128,816,000 2022-08-12
Q1 2022 Added 19,113,498 +181,855 (1.0%) 0.11% $4,790,225,000 2022-05-13
Q4 2021 Reduced 18,931,643 -1,055,035 (-5.3%) 0.11% $4,863,919,000 2022-02-14
Q3 2021 Reduced 19,986,678 -997,934 (-4.8%) 0.12% $4,851,167,000 2021-11-12
Q2 2021 Reduced 20,984,612 -30,265 (-0.1%) 0.11% $4,338,360,000 2021-08-13
Q1 2021 Added 21,014,877 +228,351 (1.1%) 0.11% $3,957,941,000 2021-05-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

1374 managers reported HCA HEALTHCARE INC COM STK for Q3 2025.

Managers reporting HCA HEALTHCARE INC COM STK in Q3 2025.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC This report Reduced 14,894,675 -580,889 0.1% $6,348,110,485 50 qtrs
BlackRock Inc Reduced 12,467,326 -483,554 0.09% $5,313,574,326 5 qtrs
Sanders Capital LLC Reduced 10,675,663 -426,920 5.6% $4,549,967,571 22 qtrs
STATE STREET CORPORATION Reduced 7,490,604 -466,059 0.11% $3,192,495,425 50 qtrs
Capital World Investors Added 4,959,336 +179,443 0.29% $2,113,661,728 9 qtrs
First Eagle Investment Management LLC Reduced 3,919,472 -290,385 3.04% $1,670,478,761 30 qtrs
WELLINGTON MANAGEMENT GROUP LLP Reduced 3,880,196 -230,117 0.29% $1,653,739,536 50 qtrs
GEODE CAPITAL MANAGEMENT LLC Reduced 3,650,140 -147,762 0.1% $1,547,861,523 50 qtrs
JPMorgan Chase & Co Reduced 2,987,069 -292,265 0.08% $1,273,089,601 50 qtrs
MORGAN STANLEY Reduced 2,129,892 -100,700 0.05% $907,760,960 50 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2025
Filed
November 07, 2025
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
166
Shared
994,638
None
13,899,871

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.